Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Eur J Clin Microbiol Infect Dis. 2016 Oct 28;36(3):517–522. doi: 10.1007/s10096-016-2827-1

Table 1.

Experimental mouse groups, interventions and culture results

Experimental Mouse Group Number Immunosuppressed Ureaplasma parvum challenge Positive culture P value*
Blood Lung Peritoneal cavity swab
Normal control (immunocompetent, uninfected) 12 No No NA NA NA 0.16
Immunosuppressed control 12 Yes No 0 0 0 0.42
IT/IP challenged immunocompetent control 12 No Yes 0 6 5 0.47
Vehicle IT/IP negative control1 16 Yes Spent broth 0 0 0 Reference
IT/IP challenge2 19 Yes Yes 0 13 9 0.0008
IP challenge3 20 Yes Yes 0 0 8 <0.0001

IT, intratracheal; IP, intraperitoneal; NA, not applicable

*

P value for ammonia concentrations compared to spent vehicle broth

1

Two deaths prior to experimental endpoint (days 10 and 12), attributed to anesthesia and IT challenge.

2

Eight deaths prior to experimental endpoint. One mouse died on day 11 after having been noted to feel cool to touch. One mouse developed bladder enlargement and died after immunosuppressive drug administration on day 11; it was not possible to assess its ammonia level but blood and bladder aspirate cultures were positive. One mouse was sacrificed on day 11 because of tachypnea, hunched stature and lethargy; cultures of blood, lung and a peritoneal swab were positive and ammonia was 955 μmol/L. Four mice died after IT/IP inoculation on day 12, of which two developed an enlarged bladder and died about 15 minutes after IT/IP inoculation with ammonia levels >1000 μmol/L and positive blood and bladder aspirate cultures. One mouse was sacrificed on day 12 because of tachypnea, hunched stature and lethargy; cultures of lung and a peritoneal swab were positive and ammonia was 326 μmol/L.

3

One death just before sacrifice on day 14; the animal had hunched stature and lethargy after inoculation on day 13.